{"url_path":"/sec/nrxp/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1719406/0001437749-26-017397-index.html","accession_number":"0001437749-26-017397","cik":"0001719406","ticker":"NRXP","issuer_name":"NRX Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719406/0001437749-26-017397-index.html","primary_entity_key":"0001719406","primary_entity_name":"NRX Pharmaceuticals, Inc."},"word_count":959,"has_tables":true,"body_markdown":"nrxp20260331_10q.htm\n\n0001719406\nNRX Pharmaceuticals, Inc.\nfalse\n--12-31\nQ1\n2026\n\n0.001\n0.001\n50,000,000\n50,000,000\n0.001\n0.001\n12,000,000\n12,000,000\n0\n0\n0\n0\n0.001\n0.001\n500,000,000\n500,000,000\n33,471,315\n33,471,315\n31,734,333\n31,734,333\n81\n0\n3\n10\n0\n5\n7\n0\n0.02\n3\nhttp://fasb.org/us-gaap/2026#SecuredOvernightFinancingRateSofrMember\n10.8\n3\n0\n0\n0\n0\n0\n0\n0.1\n50,000,000\n0\n0\n0\n5\n0\n0.1\n0\n3,448,856\n344,886\n0.1\n5\n5\n5\n5\n5\n0.316\n10\n3\n10\n120.2\n139.2\n108.42\n80.52\n118.80\n3.61\n3.64\n2\n2\n0\n3\n0.1\nfalse\nfalse\nfalse\nfalse\n\n00017194062026-01-012026-03-31\n0001719406us-gaap:CommonStockMember2026-01-012026-03-31\n0001719406us-gaap:WarrantMember2026-01-012026-03-31\nxbrli:shares\n00017194062026-05-15\nthunderdome:item\niso4217:USD\n00017194062026-03-31\n00017194062025-12-31\n0001719406us-gaap:NonrelatedPartyMember2026-03-31\n0001719406us-gaap:NonrelatedPartyMember2025-12-31\n0001719406us-gaap:RelatedPartyMember2026-03-31\n0001719406us-gaap:RelatedPartyMember2025-12-31\niso4217:USDxbrli:shares\n0001719406nrxp:NondesignatedPreferredStockMember2026-03-31\n0001719406nrxp:NondesignatedPreferredStockMember2025-12-31\n0001719406nrxp:SeriesAConvertiblePreferredStockMember2026-03-31\n0001719406nrxp:SeriesAConvertiblePreferredStockMember2025-12-31\n00017194062025-01-012025-03-31\n0001719406us-gaap:PreferredStockMember2025-12-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-12-31\n0001719406us-gaap:CommonStockMember2025-12-31\n0001719406us-gaap:AdditionalPaidInCapitalMember2025-12-31\n0001719406us-gaap:RetainedEarningsMember2025-12-31\n0001719406us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-31\n0001719406nrxp:ATMOfferingMember2026-01-012026-03-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMembernrxp:ATMOfferingMember2026-01-012026-03-31\n0001719406us-gaap:CommonStockMembernrxp:ATMOfferingMember2026-01-012026-03-31\n0001719406us-gaap:AdditionalPaidInCapitalMembernrxp:ATMOfferingMember2026-01-012026-03-31\n0001719406us-gaap:RetainedEarningsMembernrxp:ATMOfferingMember2026-01-012026-03-31\n0001719406us-gaap:AccumulatedOtherComprehensiveIncomeMembernrxp:ATMOfferingMember2026-01-012026-03-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-03-31\n0001719406us-gaap:CommonStockMember2026-01-012026-03-31\n0001719406us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-31\n0001719406us-gaap:RetainedEarningsMember2026-01-012026-03-31\n0001719406us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-31\n0001719406us-gaap:PreferredStockMember2026-03-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-03-31\n0001719406us-gaap:CommonStockMember2026-03-31\n0001719406us-gaap:AdditionalPaidInCapitalMember2026-03-31\n0001719406us-gaap:RetainedEarningsMember2026-03-31\n0001719406us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-31\n0001719406us-gaap:PreferredStockMember2024-12-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2024-12-31\n0001719406us-gaap:CommonStockMember2024-12-31\n0001719406us-gaap:AdditionalPaidInCapitalMember2024-12-31\n0001719406us-gaap:RetainedEarningsMember2024-12-31\n00017194062024-12-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-03-31\n0001719406us-gaap:CommonStockMember2025-01-012025-03-31\n0001719406us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31\n0001719406us-gaap:RetainedEarningsMember2025-01-012025-03-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMembernrxp:RegisteredDirectOfferingMember2025-01-012025-03-31\n0001719406us-gaap:CommonStockMembernrxp:RegisteredDirectOfferingMember2025-01-012025-03-31\n0001719406us-gaap:AdditionalPaidInCapitalMembernrxp:RegisteredDirectOfferingMember2025-01-012025-03-31\n0001719406us-gaap:RetainedEarningsMembernrxp:RegisteredDirectOfferingMember2025-01-012025-03-31\n0001719406nrxp:RegisteredDirectOfferingMember2025-01-012025-03-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMembernrxp:ConsiderationSharesMember2025-01-012025-03-31\n0001719406us-gaap:CommonStockMembernrxp:ConsiderationSharesMember2025-01-012025-03-31\n0001719406us-gaap:AdditionalPaidInCapitalMembernrxp:ConsiderationSharesMember2025-01-012025-03-31\n0001719406us-gaap:RetainedEarningsMembernrxp:ConsiderationSharesMember2025-01-012025-03-31\n0001719406nrxp:ConsiderationSharesMember2025-01-012025-03-31\n0001719406us-gaap:PreferredStockMember2025-03-31\n0001719406us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-03-31\n0001719406us-gaap:CommonStockMember2025-03-31\n0001719406us-gaap:AdditionalPaidInCapitalMember2025-03-31\n0001719406us-gaap:RetainedEarningsMember2025-03-31\n00017194062025-03-31\n0001719406nrxp:ConsiderationWarrantsMember2026-01-012026-03-31\n0001719406nrxp:ConsiderationWarrantsMember2025-01-012025-03-31\n0001719406nrxp:WarrantsOtherThanConsiderationWarrantsMember2026-01-012026-03-31\n0001719406nrxp:WarrantsOtherThanConsiderationWarrantsMember2025-01-012025-03-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMember2026-01-012026-03-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMember2025-01-012025-03-31\nutr:Y\n0001719406us-gaap:CustomerRelationshipsMember2026-03-31\n0001719406us-gaap:TradeNamesMember2026-03-31\n0001719406us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2026-03-31\n0001719406us-gaap:FurnitureAndFixturesMembersrt:MaximumMember2026-03-31\n0001719406us-gaap:EmployeeStockOptionMember2026-01-012026-03-31\n0001719406us-gaap:EmployeeStockOptionMember2025-01-012025-03-31\n0001719406us-gaap:WarrantMember2026-01-012026-03-31\n0001719406us-gaap:WarrantMember2025-01-012025-03-31\n0001719406us-gaap:RestrictedStockMember2026-01-012026-03-31\n0001719406us-gaap:RestrictedStockMember2025-01-012025-03-31\n0001719406nrxp:AnsonNoteMember2026-01-012026-03-31\n0001719406nrxp:AnsonNoteMember2025-01-012025-03-31\n0001719406nrxp:ProceduresMember2026-01-012026-03-31\n0001719406nrxp:TherapyMember2026-01-012026-03-31\n0001719406nrxp:CommercialInsuranceMember2026-01-012026-03-31\n0001719406nrxp:MedicareMember2026-01-012026-03-31\n0001719406us-gaap:SelfPayMember2026-01-012026-03-31\n0001719406nrxp:CommercialInsuranceMember2026-03-31\n0001719406nrxp:MedicareMember2026-03-31\n0001719406us-gaap:SelfPayMember2026-03-31\n0001719406nrxp:MedicalEquipmentMember2026-03-31\n0001719406nrxp:MedicalEquipmentMember2025-12-31\n0001719406us-gaap:ComputerEquipmentMember2026-03-31\n0001719406us-gaap:ComputerEquipmentMember2025-12-31\n0001719406us-gaap:FurnitureAndFixturesMember2026-03-31\n0001719406us-gaap:FurnitureAndFixturesMember2025-12-31\n0001719406us-gaap:LeaseholdImprovementsMember2026-03-31\n0001719406us-gaap:LeaseholdImprovementsMember2025-12-31\nxbrli:pure\n00017194062025-09-08\n0001719406nrxp:NaplesLeaseMember2025-09-08\n0001719406nrxp:FortMyersLeaseMember2025-09-08\n0001719406nrxp:WestPalmBeachLeaseMember2025-11-14\n0001719406nrxp:LeaseForCertainMedicalEquipmentAndRelatedAccessoriesMember2026-01-07\nutr:M\n0001719406us-gaap:NonrelatedPartyMember2026-01-012026-03-31\n0001719406us-gaap:RelatedPartyMember2026-01-012026-03-31\n00017194062025-01-012025-12-31\n0001719406nrxp:AlvogenLicensingAgreementMember2024-06-212024-06-21\n0001719406nrxp:AlvogenLicensingAgreementMember2026-03-31\n0001719406nrxp:AlvogenLicensingAgreementMember2025-12-31\n0001719406nrxp:AlvogenLicensingAgreementMember2026-01-012026-03-31\n0001719406nrxp:AlvogenLicensingAgreementMember2025-01-012025-12-31\n0001719406nrxp:AnsonConvertibleNotesMember2024-08-12\n0001719406nrxp:AnsonWarrantsMember2024-08-12\n0001719406nrxp:AnsonFirstTrancheNotesMember2024-08-14\n0001719406nrxp:AnsonFirstTrancheNotesMember2024-08-142024-08-14\n0001719406nrxp:AnsonWarrantsMember2024-08-14\n0001719406nrxp:AnsonSecondTrancheNotesMember2024-10-10\n0001719406nrxp:AnsonSecondTrancheNotesMember2024-10-102024-10-10\n0001719406nrxp:AnsonThirdTrancheNotesMember2025-01-28\n0001719406nrxp:AnsonThirdTrancheNotesMember2025-01-282025-01-28\n0001719406nrxp:ThirdTrancheNotesWarrantsMember2025-01-28\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonConvertibleNotesMember2024-01-012024-12-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonFirstTrancheNotesMember2024-01-012024-12-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonFirstTrancheNotesMember2025-01-012025-03-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonThirdTrancheNotesMembersrt:MaximumMember2025-01-012025-03-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonThirdTrancheNotesMember2025-01-012025-03-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonConvertibleNotesMember2025-01-012025-12-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonSecondTrancheNotesMember2025-01-012025-12-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonThirdTrancheNotesMember2025-01-012025-12-31\n0001719406nrxp:AnsonConvertibleNotesMember2026-03-31\n0001719406nrxp:AnsonConvertibleNotesMember2025-12-31\n0001719406nrxp:AnsonConvertibleNotesMember2025-01-012025-03-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonThirdTrancheNotesMember2025-01-202025-01-20\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonThirdTrancheNotesMember2025-03-202025-03-20\n0001719406nrxp:ConsentAndWaiverAgreementMember2025-03-202025-03-20\n0001719406nrxp:ConsiderationWarrantsMember2025-03-202025-03-20\n0001719406nrxp:AnsonSecondTrancheNotesMember2025-12-31\n0001719406nrxp:AnsonWarrantsMember2025-12-31\n0001719406nrxp:AnsonWarrantsMember2025-09-30\n0001719406nrxp:AnsonWarrantsMember2025-09-302025-09-30\n0001719406nrxp:AnsonConvertibleNotesMember2025-01-012025-12-31\n0001719406nrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:EndOfPhaseIClinicalTrialsOfLicensedProductMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:EndOfPhaseIIClinicalTrialsOfLicensedProductMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:EndOfPhaseIIIClinicalTrialsOfLicensedProductMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:FirstCommercialSaleOfLicensedProductInUsMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:FirstCommercialSaleOfLicensedProductInEuropeMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:AnnualRevenueThresholdMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-03-31\n0001719406nrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2025-01-012025-03-31\n0001719406nrxp:ProductsCoveredByLicensedPatentsMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-03-31\n0001719406nrxp:ProductsCoveredByValidClaimsMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-03-31\n0001719406srt:MaximumMembernrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2026-03-31\n0001719406nrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2021-04-162021-04-16\n0001719406nrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2022-04-16\n0001719406nrxp:SarahHerzogMemorialHospitalLicenseAgreementMember2025-01-012025-12-31\n0001719406nrxp:StockIssuanceToVendorMember2025-04-16\n0001719406nrxp:StockIssuanceToVendorMember2025-05-152025-05-15\n0001719406nrxp:StockIssuanceToVendorMember2025-05-15\n0001719406nrxp:StockIssuanceToVendorMember2025-01-012025-12-31\n0001719406nrxp:AnnualMaintenanceFeesMember2026-01-012026-03-31\n0001719406nrxp:AnnualMaintenanceFeesMember2025-01-012025-03-31\n0001719406nrxp:PatentLicenseMembernrxp:ExclusiveLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:PatentLicenseMembernrxp:ExclusiveLicenseAgreementMember2025-01-012025-03-31\n0001719406nrxp:OfficeSpaceLeasesMember2026-01-012026-03-31\n0001719406us-gaap:SeriesAPreferredStockMember2026-03-31\n0001719406us-gaap:SeriesAPreferredStockMember2023-08-012023-08-31\n0001719406nrxp:ConversionOfSeriesAPreferredStockToCommonStockMember2024-01-012024-03-31\n0001719406nrxp:ConversionOfSeriesAPreferredStockToCommonStockMember2024-03-012024-03-31\n0001719406us-gaap:SeriesAPreferredStockMember2025-12-31\n0001719406nrxp:ATMOfferingMember2024-02-202024-07-29\n0001719406srt:MinimumMembernrxp:ATMOfferingMember2024-07-29\n0001719406srt:MaximumMembernrxp:ATMOfferingMember2024-07-29\n0001719406nrxp:ATMOfferingMember2023-08-14\n0001719406nrxp:ATMOfferingMember2025-04-17\n0001719406nrxp:ATMOfferingMember2025-01-012025-03-31\n0001719406nrxp:RDPurchaseAgreementMember2025-01-272025-01-27\n0001719406nrxp:RDPurchaseAgreementMember2025-01-27\n0001719406nrxp:RDPurchaseAgreementMember2025-01-27\n0001719406nrxp:RDPurchaseAgreementMember2025-01-292025-01-29\n0001719406nrxp:RDPurchaseAgreementMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2025-01-29\n0001719406nrxp:RDPurchaseAgreementMemberus-gaap:MeasurementInputSharePriceMember2025-01-29\n0001719406nrxp:RDPurchaseAgreementMemberus-gaap:MeasurementInputExercisePriceMember2025-01-29\n0001719406nrxp:RDPurchaseAgreementMemberus-gaap:MeasurementInputExpectedTermMember2025-01-29\n0001719406nrxp:RDPurchaseAgreementMemberus-gaap:MeasurementInputPriceVolatilityMember2025-01-29\n0001719406nrxp:RDPurchaseAgreementMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-01-29\n0001719406nrxp:RDPurchaseAgreementMember2025-01-292025-01-29\n0001719406nrxp:RDPurchaseAgreementMember2025-01-012025-12-31\n0001719406nrxp:RDPurchaseAgreementMember2025-03-20\n0001719406nrxp:ConsentAndWaiverAgreementMember2025-01-012025-09-30\n0001719406nrxp:NeuroRxMembernrxp:SubstituteWarrantsMember2021-05-24\n0001719406nrxp:PublicWarrantsMember2021-05-24\n0001719406nrxp:PublicWarrantsMember2025-01-012025-12-31\n0001719406nrxp:PublicWarrantsMember2024-01-012024-12-31\n0001719406nrxp:PublicWarrantsMember2026-03-31\n0001719406nrxp:PublicWarrantsMember2025-12-31\n0001719406nrxp:PrivatePlacementWarrantsMember2026-03-31\n0001719406nrxp:PrivatePlacementWarrantsMember2026-01-012026-03-31\n0001719406nrxp:PrivatePlacementWarrantsMember2025-01-012025-03-31\n0001719406us-gaap:PrivatePlacementMember2024-02-282024-02-28\n0001719406nrxp:FebruaryWarrantsMemberus-gaap:PrivatePlacementMember2024-02-28\n0001719406nrxp:FebruaryWarrantsMember2024-02-282024-02-28\n0001719406nrxp:FebruaryWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-02-28\n0001719406nrxp:FebruaryWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2024-02-28\n0001719406nrxp:FebruaryWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-02-28\n0001719406nrxp:FebruaryWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-02-28\n0001719406nrxp:FebruaryWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-02-28\n0001719406nrxp:FebruaryWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-02-28\n0001719406nrxp:FebruaryUnderwriterWarrantsMember2024-02-28\n0001719406nrxp:FebruaryUnderwriterWarrantsMember2024-02-282024-02-28\n0001719406nrxp:FebruaryUnderwriterWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-02-28\n0001719406nrxp:FebruaryUnderwriterWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2024-02-28\n0001719406nrxp:FebruaryUnderwriterWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-02-28\n0001719406nrxp:FebruaryUnderwriterWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-02-28\n0001719406nrxp:FebruaryUnderwriterWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-02-28\n0001719406nrxp:FebruaryUnderwriterWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-02-28\n0001719406nrxp:UnderwriterOverallotmentWarrantsMember2024-03-05\n0001719406nrxp:UnderwriterOverallotmentWarrantsMember2024-03-052024-03-05\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-03-05\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2024-03-05\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-03-05\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-03-05\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-03-05\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-03-05\n0001719406nrxp:AprilUnderwriterWarrantsMembernrxp:April2024OfferingMember2024-04-19\n0001719406nrxp:AprilUnderwriterWarrantsMember2024-04-192024-04-19\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-04-19\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2024-04-19\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-04-19\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-04-19\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-04-19\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-04-19\n0001719406nrxp:AprilUnderwriterWarrantsMembernrxp:April2024OfferingMember2024-05-23\n0001719406nrxp:AprilUnderwriterOverallotmentWarrantsMember2024-05-232024-05-23\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-05-23\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2024-05-23\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-05-23\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-05-23\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-05-23\n0001719406nrxp:UnderwriterOverallotmentWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-05-23\n0001719406nrxp:AlvogenAndLotusWarrantsMember2024-02-07\n0001719406nrxp:AlvogenAndLotusWarrantsMember2024-02-072024-02-07\n0001719406nrxp:AlvogenAndLotusWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-02-07\n0001719406nrxp:AlvogenAndLotusWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2024-02-07\n0001719406nrxp:AlvogenAndLotusWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-02-07\n0001719406nrxp:AlvogenAndLotusWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-02-07\n0001719406nrxp:AlvogenAndLotusWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-02-07\n0001719406nrxp:AlvogenAndLotusWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-02-07\n0001719406nrxp:AnsonWarrantsTrancheOneMember2024-08-14\n0001719406nrxp:AnsonWarrantsTrancheOneMember2024-08-142024-08-14\n0001719406nrxp:AnsonWarrantsTrancheOneMemberus-gaap:MeasurementInputSharePriceMember2024-08-14\n0001719406nrxp:AnsonWarrantsTrancheOneMemberus-gaap:MeasurementInputExercisePriceMember2024-08-14\n0001719406nrxp:AnsonWarrantsTrancheOneMemberus-gaap:MeasurementInputExpectedTermMember2024-08-14\n0001719406nrxp:AnsonWarrantsTrancheOneMemberus-gaap:MeasurementInputPriceVolatilityMember2024-08-14\n0001719406nrxp:AnsonWarrantsTrancheOneMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-08-14\n0001719406nrxp:AnsonWarrantsTrancheOneMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-08-14\n0001719406nrxp:AnsonWarrantsTrancheTwoMember2024-10-10\n0001719406nrxp:AnsonWarrantsTrancheTwoMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-10-10\n0001719406nrxp:AnsonWarrantsTrancheTwoMemberus-gaap:MeasurementInputSharePriceMember2024-10-10\n0001719406nrxp:AnsonWarrantsTrancheTwoMemberus-gaap:MeasurementInputExercisePriceMember2024-10-10\n0001719406nrxp:AnsonWarrantsTrancheTwoMemberus-gaap:MeasurementInputExpectedTermMember2024-10-10\n0001719406nrxp:AnsonWarrantsTrancheTwoMemberus-gaap:MeasurementInputPriceVolatilityMember2024-10-10\n0001719406nrxp:AnsonWarrantsTrancheTwoMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-10-10\n0001719406nrxp:AnsonWarrantsTrancheTwoMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-10-10\n0001719406nrxp:AnsonWarrantsTrancheThreeMember2025-01-28\n0001719406nrxp:AnsonWarrantsTrancheThreeMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2025-01-28\n0001719406nrxp:AnsonWarrantsTrancheThreeMemberus-gaap:MeasurementInputSharePriceMember2025-01-28\n0001719406nrxp:AnsonWarrantsTrancheThreeMemberus-gaap:MeasurementInputExercisePriceMember2025-01-28\n0001719406nrxp:AnsonWarrantsTrancheThreeMemberus-gaap:MeasurementInputExpectedTermMember2025-01-28\n0001719406nrxp:AnsonWarrantsTrancheThreeMemberus-gaap:MeasurementInputPriceVolatilityMember2025-01-28\n0001719406nrxp:AnsonWarrantsTrancheThreeMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-01-28\n0001719406nrxp:AnsonWarrantsTrancheThreeMemberus-gaap:MeasurementInputExpectedDividendRateMember2025-01-28\n0001719406nrxp:AmendedAnsonWarrantsMember2025-09-302025-09-30\n0001719406nrxp:RDPurchaseAgreementMember2025-01-29\n0001719406nrxp:ConsiderationWarrantsMember2025-03-20\n0001719406nrxp:ConsiderationWarrantsMemberus-gaap:MeasurementInputSharePriceMember2025-03-20\n0001719406nrxp:ConsiderationWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2025-03-20\n0001719406nrxp:ConsiderationWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2025-03-20\n0001719406nrxp:ConsiderationWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2025-03-20\n0001719406nrxp:ConsiderationWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-03-20\n0001719406us-gaap:EstimateOfFairValueFairValueDisclosureMember2026-03-31\n0001719406nrxp:AnsonWarrantsMember2026-01-012026-03-31\n00017194062024-01-012024-12-31\n0001719406nrxp:The2016OmnibusIncentivePlanMember2026-03-31\n0001719406nrxp:NeuroRxMembernrxp:The2016OmnibusIncentivePlanMember2021-05-24\n0001719406nrxp:The2021OmnibusIncentivePlanMember2025-12-31\n0001719406nrxp:The2021OmnibusIncentivePlanMember2026-01-012026-01-01\n0001719406nrxp:The2021OmnibusIncentivePlanMember2022-01-01\n0001719406nrxp:The2021OmnibusIncentivePlanMember2023-12-282023-12-28\n0001719406nrxp:The2021OmnibusIncentivePlanMember2026-01-012026-03-31\n0001719406nrxp:The2021OmnibusIncentivePlanMember2026-03-31\n0001719406us-gaap:EmployeeStockOptionMember2026-01-012026-03-31\n0001719406us-gaap:EmployeeStockOptionMember2026-01-012026-01-01\n0001719406us-gaap:EmployeeStockOptionMember2026-01-272026-01-27\n0001719406us-gaap:EmployeeStockOptionMembersrt:MinimumMember2026-03-31\n0001719406us-gaap:EmployeeStockOptionMembersrt:MaximumMember2026-03-31\n0001719406us-gaap:EmployeeStockOptionMember2025-01-012025-03-31\n0001719406us-gaap:EmployeeStockOptionMember2026-03-31\n0001719406us-gaap:RestrictedStockMember2024-12-31\n0001719406us-gaap:RestrictedStockMember2025-01-012025-12-31\n0001719406us-gaap:RestrictedStockMember2025-12-31\n0001719406us-gaap:RestrictedStockMember2026-01-012026-03-31\n0001719406us-gaap:RestrictedStockMember2026-03-31\n0001719406us-gaap:RestrictedStockMembernrxp:EmployeeMember2025-10-222025-10-22\n0001719406us-gaap:SellingGeneralAndAdministrativeExpense2026-01-012026-03-31\n0001719406us-gaap:SellingGeneralAndAdministrativeExpense2025-01-012025-03-31\n0001719406us-gaap:ResearchAndDevelopmentExpense2026-01-012026-03-31\n0001719406us-gaap:ResearchAndDevelopmentExpense2025-01-012025-03-31\n0001719406us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2026-03-31\n0001719406us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-31\n0001719406us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-03-31\n0001719406us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-31\n0001719406nrxp:AnsonConvertibleNotesMemberus-gaap:MeasurementInputSharePriceMember2025-03-31\n0001719406nrxp:AnsonConvertibleNotesMemberus-gaap:MeasurementInputExpectedTermMembersrt:MinimumMember2025-03-31\n0001719406nrxp:AnsonConvertibleNotesMemberus-gaap:MeasurementInputExpectedTermMembersrt:MaximumMember2025-03-31\n0001719406nrxp:AnsonConvertibleNotesMembernrxp:MeasurementInputCostOfDebtMember2025-03-31\n0001719406nrxp:AnsonConvertibleNotesMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MinimumMember2025-03-31\n0001719406nrxp:AnsonConvertibleNotesMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MaximumMember2025-03-31\n0001719406nrxp:AnsonConvertibleNotesMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-03-31\n0001719406nrxp:AnsonConvertibleNotesMembernrxp:MeasurementInputProbabilityOfDefaultMember2025-03-31\n0001719406nrxp:AnsonConvertibleNotesMember2024-12-31\n0001719406nrxp:AnsonConvertibleNotesMember2025-01-012025-03-31\n0001719406nrxp:AnsonConvertibleNotesMember2025-03-31\n0001719406nrxp:ConversionOfPrincipalAndInterestIntoCommonStockMembernrxp:AnsonNoteMember2025-04-012025-12-31\n0001719406nrxp:AnsonNoteMember2025-04-012025-12-31\n0001719406nrxp:AnsonNoteMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputSharePriceMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputSharePriceMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExercisePriceMembersrt:MinimumMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExercisePriceMembersrt:MaximumMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExercisePriceMembersrt:MinimumMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExercisePriceMembersrt:MaximumMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExpectedTermMembersrt:MinimumMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExpectedTermMembersrt:MaximumMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExpectedTermMembersrt:MinimumMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExpectedTermMembersrt:MaximumMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MinimumMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MaximumMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MinimumMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MaximumMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MinimumMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MaximumMember2025-12-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-03-31\n0001719406nrxp:WarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2025-12-31\n0001719406nrxp:WarrantsMember2026-03-31\n0001719406nrxp:WarrantsMembersrt:MinimumMember2025-12-31\n0001719406nrxp:WarrantsMembersrt:MaximumMember2025-12-31\n0001719406nrxp:WarrantsMember2025-12-31\n0001719406nrxp:WarrantsMember2026-01-012026-03-31\n0001719406us-gaap:OperatingSegmentsMembernrxp:NrxSegmentMember2026-01-012026-03-31\n0001719406us-gaap:OperatingSegmentsMembernrxp:DuraSegmentMember2026-01-012026-03-31\n0001719406us-gaap:OperatingSegmentsMember2026-01-012026-03-31\n0001719406us-gaap:OperatingSegmentsMember2025-01-012025-03-31\n0001719406us-gaap:OperatingSegmentsMembernrxp:MedicalEquipmentMembernrxp:NrxSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMembernrxp:MedicalEquipmentMembernrxp:DuraSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMembernrxp:MedicalEquipmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMembernrxp:MedicalEquipmentMember2025-12-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:ComputerEquipmentMembernrxp:NrxSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:ComputerEquipmentMembernrxp:DuraSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:ComputerEquipmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:ComputerEquipmentMember2025-12-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:FurnitureAndFixturesMembernrxp:NrxSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:FurnitureAndFixturesMembernrxp:DuraSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:FurnitureAndFixturesMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:FurnitureAndFixturesMember2025-12-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:LeaseholdImprovementsMembernrxp:NrxSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:LeaseholdImprovementsMembernrxp:DuraSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:LeaseholdImprovementsMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMemberus-gaap:LeaseholdImprovementsMember2025-12-31\n0001719406us-gaap:OperatingSegmentsMembernrxp:NrxSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMembernrxp:DuraSegmentMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMember2026-03-31\n0001719406us-gaap:OperatingSegmentsMember2025-12-31\n0001719406nrxp:DuraMedicalMember2025-09-082025-09-08\n0001719406nrxp:DuraMedicalMembernrxp:ClassAUnitsMember2025-09-082025-09-08\n0001719406nrxp:DuraMedicalMember2025-09-08\n0001719406nrxp:DuraMedicalMember2025-01-012025-12-31\n0001719406nrxp:DuraMedicalMemberus-gaap:CustomerListsMember2025-09-08\n0001719406nrxp:DuraMedicalMemberus-gaap:TradeNamesMember2025-09-08\n0001719406nrxp:DuraMedicalMember2025-07-012025-12-31\n0001719406nrxp:DuraMedicalMemberus-gaap:TrademarksAndTradeNamesMember2025-09-082025-09-08\n0001719406nrxp:DuraMedicalMemberus-gaap:CustomerRelationshipsMember2025-09-082025-09-08\n0001719406nrxp:DuraMedicalMember2026-01-012026-03-31\n0001719406nrxp:DuraMedicalMember2026-03-31\n0001719406nrxp:DuraMedicalMember2025-12-31\n0001719406nrxp:DuraMedicalMember2025-01-012025-03-31\n0001719406nrxp:DuraMedicalMember2024-07-012024-09-30\n0001719406nrxp:GlytechLicenseAgreementMember2026-01-012026-03-31\n0001719406nrxp:GlytechLicenseAgreementMember2025-01-012025-03-31\n0001719406nrxp:NRXPharmaceuticalsIncMembersrt:MinimumMembernrxp:GlytechLicenseAgreementMember2022-11-06\n0001719406nrxp:ConsultationAgreementWithDrJonathanJavittMember2026-01-012026-03-31\n0001719406nrxp:ConsultationAgreementWithDrJonathanJavittMember2025-01-012025-03-31\n0001719406nrxp:ConsultationAgreementWithZacharyJavittMember2023-03-29\n0001719406nrxp:ConsultationAgreementWithZacharyJavittMember2026-03-31\n0001719406nrxp:ConsultationAgreementWithZacharyJavittMember2025-12-31\n0001719406nrxp:ConsultationAgreementWithZacharyJavittMember2026-01-012026-03-31\n0001719406nrxp:ConsultationAgreementWithZacharyJavittMember2025-01-012025-03-31\n0001719406nrxp:ConsultationAgreementWithZacharyJavittMemberus-gaap:RelatedPartyMember2026-03-31\n0001719406nrxp:ConsultationAgreementWithZacharyJavittMemberus-gaap:RelatedPartyMember2025-12-31\n0001719406nrxp:ConsultingAgreementWithMichaelTaylorMember2026-01-012026-03-31\n0001719406nrxp:ConsultingAgreementWithMichaelTaylorMember2025-01-012025-03-31\n0001719406nrxp:NaplesLeaseOperatingAgreementWithDuraPropertiesLlcMember2026-01-012026-03-31\n00017194062025-10-172025-10-17\n0001719406nrxp:CohenLlcMember2025-12-31\n0001719406us-gaap:SubsequentEventMembernrxp:ATMOfferingMember2026-04-012026-05-14\n0001719406srt:MaximumMemberus-gaap:SubsequentEventMembernrxp:ATMOfferingMember2026-04-012026-05-14\n\n \n\n \n\n[Table of Contents](#toc)\n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n \n\n**FORM 10-Q**\n\n \n\n**(Mark One)**\n\n \n\n**☒ QUARTERLY REPORT PURSUANT TO SECTION** **13 OR 15(d)** **OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the Quarterly Period Ended: March 31, 2026**\n\n \n\n**☐ TRANSITION REPORT PURSUANT TO SECTION** **13 OR 15(d)** **OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the transition period from to**\n\n \n\n**Commission File Number: 001-38302**\n\n \n\n**NRX PHARMACEUTICALS, INC.**\n\n(Exact name of registrant as specified in its charter)\n\n \n\n**Delaware**\n\n**82-2844431**\n\n(State or other jurisdiction of\n\n(I.R.S. Employer\n\nincorporation or organization)\n\nIdentification No.)\n\n \n\n**1201 Orange Street, Suite 600**\n\n**Wilmington, DE 19801**\n\n(Address of principal executive offices) (Zip Code)\n\n \n\n**(484) 254-6134**\n\n(Registrant’s telephone number, including area code)\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\n**Title of each class:**\n \n**Trading**\n\n**Symbol(s)**\n \n**Name of each exchange on which registered:**\n\nCommon Stock, par value $0.001 per share\n \nNRXP\n \nThe Nasdaq Stock Market LLC\n\nWarrants to purchase one share of Common Stock\n \nNRXPW\n \nThe Nasdaq Stock Market LLC\n\n \n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\n \n\nIndicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐\n\n \n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐\n\nAccelerated filer ☐\n\nNon-accelerated filer ☒\n\nSmaller reporting company ☒\n\n \nEmerging growth company ☐\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\nAs of May 15, 2026, the registrant had 36,228,992 shares of common stock, par value $0.001 per share (the “Common Stock”), outstanding.\n\n \n\n \n\n1\n\n[Table of Contents](#toc)\n\n  \n\n \n\n**TABLE OF CONTENTS**\n\n \n\n \n \n\n**Page**\n\n[**PART I **–** FINANCIAL INFORMATION**](#part1)\n\n[3](#part1)"}